(2E,4E,6Z)-3-Methyl-7-((1R,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-en-2-yl)-2,4,6-octatrienoic acid

ID: ALA1773362

PubChem CID: 54580156

Max Phase: Preclinical

Molecular Formula: C19H26O2

Molecular Weight: 286.42

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C/C(=C/C=C/C(C)=C/C(=O)O)C1=C[C@H]2CC[C@]1(C)C2(C)C

Standard InChI:  InChI=1S/C19H26O2/c1-13(11-17(20)21)7-6-8-14(2)16-12-15-9-10-19(16,5)18(15,3)4/h6-8,11-12,15H,9-10H2,1-5H3,(H,20,21)/b7-6+,13-11+,14-8-/t15-,19+/m1/s1

Standard InChI Key:  RGIRSBOJHNWSGM-RJZLKRBASA-N

Molfile:  

     RDKit          2D

 22 23  0  0  0  0  0  0  0  0999 V2000
    1.9708   -9.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8208  -12.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8208  -12.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3958  -10.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1083  -11.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6833   -9.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1083  -10.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3958   -9.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5333  -13.3792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1041  -13.3750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3916  -12.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6916   -8.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9708  -10.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2583   -9.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2583  -10.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5500   -9.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5500  -10.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0416  -10.0334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2416   -9.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2416  -10.2459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2541   -8.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2541  -11.7125    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
 11  5  1  0
 12  6  1  0
  2  5  2  0
  3  2  1  0
  4  8  1  0
  5  7  1  0
  6  1  1  0
  7  4  2  0
  8  6  2  0
  9  3  2  0
 10  3  1  0
 15 13  1  0
 14 16  1  0
 17 16  1  0
 17 15  1  0
 14 18  1  0
 18 15  1  0
 18 19  1  0
 13  1  2  0
 18 20  1  0
 14  1  1  0
 14 21  1  6
 15 22  1  6
M  END

Associated Targets(Human)

RARB Tclin Retinoic acid receptor beta (1232 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Crabp2 Cellular retinoic acid-binding protein II (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 286.42Molecular Weight (Monoisotopic): 286.1933AlogP: 4.90#Rotatable Bonds: 4
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.27CX Basic pKa: CX LogP: 4.21CX LogD: 1.23
Aromatic Rings: Heavy Atoms: 21QED Weighted: 0.59Np Likeness Score: 2.01

References

1. Okitsu T, Sato K, Iwatsuka K, Sawada N, Nakagawa K, Okano T, Yamada S, Kakuta H, Wada A..  (2011)  Replacement of the hydrophobic part of 9-cis-retinoic acid with cyclic terpenoid moiety results in RXR-selective agonistic activity.,  19  (9): [PMID:21489804] [10.1016/j.bmc.2011.03.033]

Source